Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies ; volume:2 ; number:2 ; day:9 ; month:7 ; year:2011 ; pages:197-212 ; date:8.2011
Clinical epigenetics ; 2, Heft 2 (9.7.2011), 197-212, 8.2011
- Creator
-
Mascarenhas, John
- Contributor
-
Roper, Nitin
Chaurasia, Pratima
Hoffman, Ronald
SpringerLink (Online service)
- DOI
-
10.1007/s13148-011-0050-6
- URN
-
urn:nbn:de:1111-2016072633813
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mascarenhas, John
- Roper, Nitin
- Chaurasia, Pratima
- Hoffman, Ronald
- SpringerLink (Online service)
Other Objects (12)
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
Molecular pathogenesis of the myeloproliferative neoplasms
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
Molecular pathogenesis of the myeloproliferative neoplasms
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms